EA
STJ

Euclid Advisors’s St Jude Medical STJ Stock Holding History

Euclid Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-19,260
Closed -$1.5M – 537
2016
Q2 		$1.5M Buy
19,260
+2,860
+17% +$204K 0.07% 302
2016
Q1 		$902K Sell
16,400
-8,957
-35% -$488K 0.03% 341
2015
Q4 		$1.57M Sell
25,357
-119,643
-83% -$7.55M 0.05% 295
2015
Q3 		$9.15M Sell
145,000
-16,827
-10% -$1.2M 0.41% 83
2015
Q2 		$11.8M Sell
161,827
-114,423
-41% -$8.27M 0.23% 144
2015
Q1 		$18.1M Buy
276,250
+103,250
+60% +$6.87M 0.33% 71
2014
Q4 		$11.3M Buy
173,000
+24,950
+17% +$1.61M 0.1% 196
2014
Q3 		$8.9M Buy
148,050
+8,050
+6% +$526K 0.06% 270
2014
Q2 		$9.7M Sell
140,000
-22,915
-14% -$1.49M 0.07% 269
2014
Q1 		$10.7M Buy
162,915
+43,100
+36% +$2.81M 0.08% 223
2013
Q4 		$7.42M Sell
119,815
-4,490
-4% -$260K 0.06% 280
2013
Q3 		$6.67M Buy
124,305
+27,198
+28% +$1.4M 0.07% 266
2013
Q2 		$4.43M Buy
+97,107
New +$4.21M 0.06% 322

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Euclid Advisors's STJ Position: Q3 2016 in Review

Euclid Advisors sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 19,260 shares — an estimated $1.5M sold.

Euclid Advisors first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $18.1M in Q1 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Euclid Advisors reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 19,260 St Jude Medical shares in Q3 2016, an estimated $1.5M.
  • Euclid Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Euclid Advisors's St Jude Medical position peaked at $18.1M in Q1 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.